METYRAPONE ESTEVE 250 mg, capsule molle — flacon(s) polyéthylène haute densité (PEHD) de 50 capsule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930007327
  • CIP7 3000732
  • CIS 68806037

What the source publishes

Holder
ESTEVE PHARMACEUTICALS (ESPAGNE)
Active ingredients
MÉTYRAPONE
Form
capsule molle
Package
flacon(s) polyéthylène haute densité (PEHD) de 50 capsule(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription hospitalière ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2015-02-05
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930007327
{
  "cis": "68806037",
  "cip7": "3000732",
  "form": "capsule molle",
  "name": "METYRAPONE ESTEVE 250 mg, capsule molle — flacon(s) polyéthylène haute densité (PEHD) de 50 capsule(s)",
  "cip13": "3400930007327",
  "holder": "ESTEVE PHARMACEUTICALS (ESPAGNE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "ESTEVE PHARMACEUTICALS (ESPAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "259.33",
  "authorisedOn": "2015-02-05",
  "compositions": [
    {
      "name": "MÉTYRAPONE",
      "nature": "SA",
      "strength": "250 mg",
      "linkageNumber": "1",
      "substanceCode": "31591",
      "dosageReference": "une capsule",
      "pharmaceuticalElement": "capsule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription hospitalière ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "258.31",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "METYRAPONE ESTEVE 250 mg, capsule molle",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 50 capsule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2021-03-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "MÉTYRAPONE"
  ],
  "authorisationProcedure": "Procédure de reconnaissance mutuelle",
  "prescriptionConditions": [
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930007327"